| Literature DB >> 30545158 |
Ya Zhang1, Xiangchun Zhang2, Qing Yuan3, Wenchao Niu4, Chunyu Zhang5, Jiaojiao Li6, Zhesheng He7, Yuhua Tang8, Xiaojun Ren9, Zhichao Zhang10, Pengju Cai11, Liang Gao12, Xueyun Gao13.
Abstract
Anticancer metallodrugs that aim to physiological characters unique to tumor microenvironment are expected to combat drug tolerance and side-effects. Recently, owing to the fact that reactive oxygen species' is closely related to the development of tumors, people are committed to developing metallodrugs with the capacity of improving the level of reactive oxygen species level toinduce oxidative stress in cancer cells. Herein, we demonstrated that peptide templated gold clusters with atomic precision preferably catalyze the transformation of hydrogen peroxide into superoxide anion in oxidative pressure-type tumor cells. Firstly, we successfully constructed gold clusters by rationally designing peptide sequences which targets integrin ανβ₃ overexpressed on glioblastoma cells. The superoxide anion, radical derived from hydrogen peroxide and catalyzed by gold clusters, was confirmed in vitro under pseudo-physiological conditions. Then, kinetic parameters were evaluated to verify the catalytic properties of gold clusters. Furthermore, these peptide decorated clusters can serve as special enzyme-like catalyst to convert endogenous hydrogen peroxide into superoxide anion, elevated intracellular reactive oxygen species levels, lower mitochondrial membrane potential, damage biomacromolecules, and trigger tumor cell apoptosis consequently.Entities:
Keywords: biocatalysis; gold clusters; oxidative pressure-type tumor; reactive oxygen species
Year: 2018 PMID: 30545158 PMCID: PMC6316732 DOI: 10.3390/nano8121040
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Scheme 1Schematic illustration of peptide templated gold clusters inducing tumor-specific apoptosis through enzyme-like catalysis.
Figure 1(a) Fluorescence excitation/emission spectra of AuCs. Insets present images of AuCs under visible (left) and 365 nm portable UV light (right) radiation; (b) HRTEM images of the nanoparticles derived from the clusters under the electron radiation. Size distribution (c) and MALDI-TOF MS analysis (d) of peptide-modified AuCs.
Figure 2(a) Absorbance of formazan dissolved in DMSO; (b) Peroxidase-like activity of AuCs at pH 7.0 when the temperature varies from 25 °C to 45 °C; (c) pH-dependent peroxidase-like activity of AuCs at 37 °C. Fitted curve of steady-state kinetic analyses was obtained by (d) altering the concentration of AUR with fixed 40 μM AuCs and 100 μM H2O2; (e) changing the concentration of H2O2 with fixed 40 μM AuCs.
Michaelis-Menten Constant (Km), Maximum Reaction Rate (Vmax) and Catalytic Constant (Kcat) of AuCs.
|
|
|
|
|
| H2O2 | 1.88 | 5.35 × 10−9 | 3.34 × 10−5 |
| AUR | 0.095 | 9.09 × 10−11 | 1.82 × 10−6 |
Figure 3(a) Intracellular localization of AuCs in U87-MG and HeLa cells pre-treated for 12 h. Cytotoxicity of HeLa cells (b) and U87-MG cells (c) treated by AuCs and peptide alone for 48 h (n = 5 per dose group). The peptide concentration is calculated by the ratio of peptide to gold on the basis of the corresponding AuCs concentration.
Figure 4(a) Single cell AuCs quantitative analysis in the case that cells were incubated with 40 μM AuCs for 24 and 48 h, n = 3 for each group. There is no significant difference of gold content in U87-MG cells treated for 24 h and HeLa cells treated for 48 h; (b) The cell toxicity of tumor cells treated with a series of concentration of AuCs for 24 and 48 h. Significant difference is observed between U87-MG cells treated with 40 μM AuCs for 24 h and HeLa cells treated with 40 μM AuCs for 48 h, *** p < 0.01.
Figure 5CLSM images of cellular ROS generation in U87-MG cells treated with 40 μM AuCs for 3, 6 and 12 h.
Figure 6(a) CLSM images indicating mitochondrial membrane potential change by JC-1 staining of U87-MG cells incubated with 40 μM AuCs for 3, 6, 12 h; (b) Apoptosis analysis of U87-MG cells by flow cytometry after incubation 20, 40, 60 μM AuCs for 48 h; (c) Western blot analysis of caspase-3, caspase-7, PARP, and their cleaved forms after cells were treated by 20, 40, and 60 μM AuCs for 48 h.